Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

900
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
900
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

131.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.6K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

696
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
696
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

766
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
766
The Two-State Receptor Model01:29

The Two-State Receptor Model

3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gα<sub>o/z</sub>-biased coupling profile of the dopamine D3 receptor.

Communications biology·2026
Same author

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related Analogs.

ACS chemical neuroscience·2026
Same author

Serotonergic Polypharmacology of 2-Halogenated Tryptamines.

bioRxiv : the preprint server for biology·2026
Same author

Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice.

ACS pharmacology & translational science·2026
Same author

Correction to "Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights".

ACS chemical neuroscience·2026
Same author

Transforming Amino Acids into Serotonin 5-HT<sub>2A</sub> Receptor Ligands Using Photochemistry.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: Jan 17, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.6K

Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.

Emma M Bonniwell1, Rana Alabdali2, Joseph J Hennessey1

  • 1Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.

ACS Chemical Neuroscience
|September 13, 2025
PubMed
Summary

The serotonin 2C receptor (5-HT2C) engages multiple G protein pathways, influencing its role in neuropsychiatric conditions. Understanding its diverse signaling is key for developing effective 5-HT2C therapeutics.

Keywords:
5-HT2C receptorG proteinGPCRbiased agonismpsychedelicsserotonin

More Related Videos

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.2K

Related Experiment Videos

Last Updated: Jan 17, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.6K
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.2K

Area of Science:

  • Neuropharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • The serotonin 2C receptor (5-HT2C) is a G protein-coupled receptor (GPCR) targeted for neuropsychiatric disorders like depression and obesity.
  • Its signaling complexity is not fully understood, potentially limiting drug efficacy and causing side effects.
  • Renewed interest in psychedelics for depression highlights the need to clarify 5-HT2C's role in their therapeutic effects.

Purpose of the Study:

  • To comprehensively analyze the signaling pathways of the serotonin 2C receptor (5-HT2C).
  • To investigate the impact of RNA editing on 5-HT2C signaling.
  • To characterize the signaling profiles of various 5-HT2C ligands, including psychedelics.

Main Methods:

  • Comprehensive analysis of 5-HT2C G protein coupling and β-arrestin recruitment.
  • Assessment of signaling changes due to increased RNA editing of the receptor.
  • Profiling of 5-HT2C-selective and psychedelic ligands, including LSD and psilocin.

Main Results:

  • 5-HT2C receptor couples to Gi/o/z and G12/13 proteins, in addition to the primary Gq/11 pathway.
  • The receptor preferentially recruits β-arrestin2 over β-arrestin1.
  • Increased RNA editing attenuates G protein signaling, particularly G12/13, while preserving β-arrestin recruitment.
  • Serotonergic psychedelics like LSD and psilocin show a Gq/11 bias with minimal secondary G protein activation.

Conclusions:

  • This study elucidates the multifaceted signaling landscape of the 5-HT2C receptor.
  • RNA editing significantly modulates 5-HT2C signaling pathways.
  • Ligand-specific signaling profiles, especially the Gq/11 bias of psychedelics, offer insights for drug development.
  • A broader understanding of 5-HT2C signaling is crucial for advancing therapeutic strategies for neuropsychiatric conditions.